Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35017768 | chr1:40520019 | C/T | 0.000336 | 174 | 25.2 | 28.3 | 25.17 | KM Plot |
PCPG | rs35021324 | chr10:29854488 | C/T | 5.71E-11 | 176 | 25.77 | 16.83 | 10.3 | KM Plot |
PCPG | rs35028238 | chr2:24315345 | C/CT | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs35031161 | chr2:242596439 | A/G | 6.19E-11 | 175 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs35033542 | chr14:74583549 | C/A | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs35039887 | chr2:24333701 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs35045018 | chr14:74585102 | G/A | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs35052325 | chr3:39171676 | C/T | 8.0E-6 | 174 | 25.67 | 21.95 | 19.87 | KM Plot |
PCPG | rs35052753 | chr14:74488992 | T/G | 3.72E-7 | 178 | 25.28 | 28.38 | 7.4 | KM Plot |
PCPG | rs35054095 | chr17:50303521 | C/T | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs35056340 | chr2:2752889 | CA/C | 2.96E-5 | 170 | 25.67 | 23.43 | 21.68 | KM Plot |
PCPG | rs35059499 | chr2:24340373 | C/T | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs35076015 | chr3:53026366 | C/T | 6.73E-6 | 176 | 25.28 | 26.05 | 11.78 | KM Plot |
PCPG | rs35088691 | chr15:43064763 | T/C | 2.28E-13 | 176 | 25.53 | 24.62 | 25.17 | KM Plot |
PCPG | rs35088714 | chr14:74334205 | TA/T | 1.12E-5 | 175 | 25.47 | 28.3 | 10.43 | KM Plot |